tourette’s
Teva’s Austedo fails in two paediatric Tourette’s syndrome trials
February 21, 2020Medical Communications, Research and Development Austedo, Teva, pharma, tourette's
Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …
Lundbeck acquire Abide Therapeutics in deal worth $400 million
May 7, 2019Manufacturing and Production, Sales and Marketing Abide Therapeutics, Lundbeck, endocannabinoid system, neuropathic pain, tourette's
Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million. …
Neurocrine’s Ingrezza flops in Tourette’s for second time
May 25, 2017Research and Development, Sales and Marketing Neurocrine Biosciences, tourette's
Neurocrine’s Tourette’s therapy Ingrezza (valbenazine) has been hit with yet another setback, flopping in a Phase 2 trial of paediatric …
